Oxford wins FDA nod for patient-specific cranial system

02/19/2013 | BeckersASC.com

The FDA has given Oxford Performance Materials 510(k) clearance to market its OsteoFab system. The implantable device, which is tailored to each patient, is designed to help replace skull voids caused by disease or trauma.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC